Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia.

Authors	Guido Finazzi, Alessandra Carobbio, Paola Guglielmelli, Chiara Cavalloni, Silvia Salmoiraghi, Alessandro M Vannucchi, Mario Cazzola, Francesco Passamonti, Alessandro Rambaldi, Tiziano Barbui
Journal	Blood (Blood) Vol. 124 Issue 16 Pg. 2611-2 (Oct 16 2014) ISSN: 1528-0020 [Electronic] United States
PMID	25323688 (Publication Type: Letter)
Chemical References	Calreticulin Janus Kinase 2
Topics	Adult Aged Aged, 80 and over Calreticulin (genetics) Female Humans Janus Kinase 2 (genetics) Male Middle Aged Mutation Prognosis Risk Factors Thrombocythemia, Essential (complications, genetics) Thrombosis (diagnosis, etiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!